CN108727408B - Pyridofuroxan energetic compound and preparation method thereof - Google Patents

Pyridofuroxan energetic compound and preparation method thereof Download PDF

Info

Publication number
CN108727408B
CN108727408B CN201710251607.0A CN201710251607A CN108727408B CN 108727408 B CN108727408 B CN 108727408B CN 201710251607 A CN201710251607 A CN 201710251607A CN 108727408 B CN108727408 B CN 108727408B
Authority
CN
China
Prior art keywords
reaction
amino
compound
dinitropyridine
dichloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201710251607.0A
Other languages
Chinese (zh)
Other versions
CN108727408A (en
Inventor
马丛明
刘祖亮
姚其正
周九九
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Science and Technology
Original Assignee
Nanjing University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Science and Technology filed Critical Nanjing University of Science and Technology
Priority to CN201710251607.0A priority Critical patent/CN108727408B/en
Publication of CN108727408A publication Critical patent/CN108727408A/en
Application granted granted Critical
Publication of CN108727408B publication Critical patent/CN108727408B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention discloses a pyridofuroxan energetic compound and a preparation method thereof. The method comprises the steps of realizing the ring-closing reaction of 4-amino-2, 6-dichloro-3, 5-dinitropyridine with azide and denitrification at a certain temperature, decompressing and rotary-steaming a mixture after the reaction is finished, adding water for dissolving, drying an organic phase by anhydrous sodium sulfate after extraction, filtering, decompressing and rotary-steaming a filtrate. The synthesized energetic compound has the advantages of novel structure, mild reaction conditions, no need of special devices, simple process and operation process, safe and reliable production, convenient and fast post-treatment of products and small environmental pollution, and meets the basic requirements of industrial scale-up production; the compound has the structures of tetrazole, furazan oxide and amino nitropyridine, has potential application in the field of energetic materials, and has the detonation velocity of 8754m/s in theoretical calculation.

Description

Pyridofuroxan energetic compound and preparation method thereof
Technical Field
The invention belongs to the technical field of explosive synthesis processes, and particularly relates to a synthesis method of an energetic compound 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide.
Background
In the field of energetic materials, an energetic derivative taking a furazan oxide group as an explosive group has the following characteristics: 1) furazan oxide groups can provide relatively higher energy densities; 2) the effective oxygen content is high, and the furoxan derivative as an energetic additive can improve the oxygen balance of a system; 3) the furoxan group can endow the derivative with ring tension and high standard formation enthalpy. If one nitro group is replaced by one furazan oxide group, the density can be improved by 0.06-0.08 g/cm3The detonation velocity can be improved by 300 m/s. Furthermore, the introduction of heterocyclic systems may greatly favor combinations of their atomic orbitals over carbocyclic systems due to intramolecular perturbations, since heteroatoms play an important role in the lowest molecular orbital level. But additionallyThe stabilization effect brought by the charge density can often improve the heat resistance of the explosive and reduce the mechanical sensitivity of the explosive. The introduction of ortho amino and nitro groups on the pyridine ring to form intramolecular and intermolecular hydrogen bonds can improve the safety performance and crystal density of energetic compounds; the introduction of nitrogen-rich compounds increases the energy of the energy-containing compounds. However, researchers at home and abroad have only reported on compounds having tetrazole, furazan oxide and amino nitropyridine structures.
J Energ Mater,2005,23(2):99-106 reported that a synthetic route of an energetic compound having tetrazole, furazan oxide groups is shown as follows. The route takes 2, 6-dimethoxy pyridine as a raw material, and 7-nitrotetrazolyl [1,5-f ] furazano [4,5-b ] pyridine-1-oxide (NFP) is synthesized by nitration, hydrazine substitution, azidation and pyrolysis denitrification, and the decomposition point is about 160 ℃. The method has long synthetic route and low utilization rate of substituent groups of pyridine rings.
Figure BDA0001272240270000021
Chin J Chem,2013,31:1299-1304 reports a synthetic route of an energy-containing compound with a furazan oxide ring and an amino nitropyridine structure as shown in the following formula. The method takes 2-chloro-4-aminopyridine as a raw material, takes ethanol/water as a solvent, completes an azidation reaction at room temperature, and performs pyrolysis denitrification and ring closure under an acidic condition to obtain the 7-amino-6-nitro- [1,2,5] oxadiazol [3,4-b ] pyridine-1-oxide. The theoretical calculation detonation velocity of the compound is only 7.51km/s, and the detonation performance of the pyridine ring series energetic compound cannot be fully exerted.
Figure BDA0001272240270000022
Disclosure of Invention
The invention aims to provide a pyridofuroxan energetic compound 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide and a preparation method thereof.
In order to solve the technical problems, the invention adopts a technical scheme that:
a pyridofuroxan energetic compound (named 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide) has the following structure:
Figure BDA0001272240270000031
the preparation method of the compound comprises the following steps:
dissolving 4-amino-2, 6-dichloro-3, 5-dinitropyridine in an organic solvent, adding sodium azide at room temperature, and stirring for reaction for more than 30 min;
and secondly, adding a small amount of concentrated hydrochloric acid into the reaction mixed solution, heating to react for a period of time, evaporating the solvent from the mixed solution under reduced pressure after the reaction is finished, adding water to dissolve the solvent, extracting with ethyl acetate, drying the organic phase, and distilling under reduced pressure to obtain the target compound.
Wherein, in the first step, the mol ratio of the 4-amino-2, 6-dichloro-3, 5-dinitropyridine to the sodium azide is 1:2-1: 4.
In the first step, the organic solvent comprises acetonitrile, ethyl acetate, tetrahydrofuran, acetone, methanol, ethanol and a mixture thereof, preferably any one or a combination of acetonitrile, tetrahydrofuran and acetone.
In the second step, the mass of the concentrated hydrochloric acid is 1/20-1/30 of 4-amino-2, 6-dichloro-3, 5-dinitropyridine, the reaction temperature of the mixed solution is 30-50 ℃, and the reaction time is 1-3 hours.
Compared with the prior art, the invention has the following remarkable advantages: the invention synthesizes the fully-substituted pyridofuroxan energetic compound for the first time: the 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide has the advantages of simple synthesis reaction steps, mild conditions, no need of special devices, safe and reliable production, simple product post-treatment, small environmental hazard and capability of meeting the basic requirements of industrial amplification production; the compound has the structure of tetrazole, furazan oxide and amino nitropyridine, the detonation velocity is 8754m/s theoretically calculated, and the compound can be possibly used in the field of high-energy insensitive energetic materials.
The present invention is described in further detail below with reference to the attached drawing figures.
Drawings
FIG. 1 of pyridofuroxan energetic compounds of the invention1H NMR spectrum.
Detailed Description
The following detailed description of the preferred embodiments of the present invention is provided to enable those skilled in the art to more readily understand the advantages and features of the present invention, and to clearly and unequivocally define the scope of the present invention.
The 4-amino-5-nitro- [1,2,5] of the invention]Oxadiazole [3,4-e ] s]Tetrazole [1,5-a ]]Pyridine-3-oxides having the formula C5H2N8O4The structural formula is as follows:
Figure BDA0001272240270000041
the synthetic route of the 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide is as follows:
Figure BDA0001272240270000042
the invention relates to a preparation method of 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide, which comprises the following steps:
dissolving 4-amino-2, 6-dichloro-3, 5-dinitropyridine in a proper solvent, adding sodium azide at room temperature, and stirring for reaction for 1 h;
and secondly, adding a small amount of concentrated hydrochloric acid into the reaction mixed solution, heating to react for a period of time, evaporating the solvent from the mixed solution under reduced pressure after the reaction is finished, adding water to dissolve the solvent, extracting the mixture by ethyl acetate, drying an organic phase, and distilling under reduced pressure to obtain the 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide.
Wherein, in the first step, the mol ratio of the 4-amino-2, 6-dichloro-3, 5-dinitropyridine to the sodium azide is 1:2-1:4, and the solvent for dissolving the 4-amino-2, 6-dichloro-3, 5-dinitropyridine comprises acetonitrile, ethyl acetate, tetrahydrofuran, acetone, methanol, ethanol and a mixture thereof. Wherein, the reaction solvent preferably comprises acetonitrile, tetrahydrofuran and acetone.
In the second step, the mass of the concentrated hydrochloric acid is 1/20-1/30 of 4-amino-2, 6-dichloro-3, 5-dinitropyridine, the reaction temperature of the mixed solution is 30-50 ℃, and the reaction time is 1-3 hours.
Example 1
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine was dissolved in 15mL of acetonitrile, and 0.65g (10mmol) of sodium azide was added thereto at room temperature under stirring, followed by reaction with stirring for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 30 ℃ for reaction for 3 hours. After the reaction is finished, the mixed solution is decompressed and steamed, dissolved by adding water, extracted by ethyl acetate, dried and filtered by the organic phase, and the filtrate is decompressed and distilled to obtain yellow solid 4-amino-5-nitro- [1,2, 5-nitro- [1]Oxadiazole [3,4-e ] s]Tetrazole [1,5-a ]]Pyridine-3-oxide 0.89g, yield 75%. m.p.150-151 ℃ (dec.);1H NMR(DMSO-d6,400MHz):δ10.17(s,1H),9.50(s,1H);13C NMR(DMSO-d6100MHz) delta 148.96,144.27,141.87,111.17,105.06; MS (ESI) M/z:239.0(M + H), see FIG. 1.
The compound has the structures of tetrazole, furazan oxide and amino nitropyridine, the detonation velocity is calculated up to 8754m/s theoretically, and the compound has potential application in the field of high-energy insensitive energetic materials.
Example 2
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine is dissolved in 15mL of a mixed solvent of ethyl acetate and acetone, 0.98g (15mmol) of sodium azide is added under stirring at room temperature, and the mixture is stirred and reacted for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 35 ℃ for reaction for 2.5 h. After the reaction, the mixture was rotary-distilled under reduced pressure, dissolved in water, extracted with ethyl acetate, the organic phase was dried, filtered, and the filtrate was distilled under reduced pressure to give 0.71g of 4-amino-5-nitro- [1,2,5] oxadiazol [3,4-e ] tetrazolo [1,5-a ] pyridine-3-oxide as a yellow solid in 60% yield.
Example 3
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine is dissolved in 15mL of ethanol, 0.98g (15mmol) of sodium azide is added under stirring at room temperature, and the mixture is stirred and reacted for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 50 ℃ for reaction for 1.5 h. After the reaction, the mixture was rotary-distilled under reduced pressure, dissolved in water, extracted with ethyl acetate, the organic phase was dried, filtered, and the filtrate was distilled under reduced pressure to give 0.62g of 4-amino-5-nitro- [1,2,5] oxadiazol [3,4-e ] tetrazolo [1,5-a ] pyridine-3-oxide as a yellow solid in 52% yield.
Example 4
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine was dissolved in 15mL of acetone, and 1.30g (20mmol) of sodium azide was added thereto at room temperature with stirring, followed by reaction with stirring for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 30 ℃ for reaction for 2 hours. After the reaction, the mixture was rotary-distilled under reduced pressure, dissolved in water, extracted with ethyl acetate, the organic phase was dried, filtered, and the filtrate was distilled under reduced pressure to give 0.80g of 4-amino-5-nitro- [1,2,5] oxadiazol [3,4-e ] tetrazolo [1,5-a ] pyridine-3-oxide as a yellow solid in 67% yield.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes performed by the present specification and drawings, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.

Claims (7)

1. A pyridofuroxan energetic compound is characterized by having the following structure:
Figure FDA0001272240260000011
2. a process for the preparation of a compound according to claim 1, comprising the steps of:
dissolving 4-amino-2, 6-dichloro-3, 5-dinitropyridine in an organic solvent, adding sodium azide at room temperature, and stirring for reaction for more than 30 min;
and secondly, adding a small amount of concentrated hydrochloric acid into the reaction mixed solution, heating to react for a period of time, evaporating the solvent from the mixed solution under reduced pressure after the reaction is finished, adding water to dissolve the solvent, extracting with ethyl acetate, drying the organic phase, and distilling under reduced pressure to obtain the target compound.
3. The method of claim 2, wherein in the first step, the molar ratio of 4-amino-2, 6-dichloro-3, 5-dinitropyridine to sodium azide is 1:2 to 1: 4.
4. The method of claim 2, wherein in the first step, the organic solvent comprises acetonitrile, ethyl acetate, tetrahydrofuran, acetone, methanol, ethanol, and mixtures thereof.
5. The method of claim 2, wherein in the first step, the organic solvent comprises any one or a combination of acetonitrile, tetrahydrofuran, and acetone.
6. The method according to claim 2, wherein in the second step, the mass of the concentrated hydrochloric acid is 1/20-1/30 of the mass of the 4-amino-2, 6-dichloro-3, 5-dinitropyridine.
7. The method of claim 2, wherein the reaction temperature of the mixed solution in the second step is 30 to 50 ℃ and the reaction time is 1 to 3 hours.
CN201710251607.0A 2017-04-18 2017-04-18 Pyridofuroxan energetic compound and preparation method thereof Expired - Fee Related CN108727408B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710251607.0A CN108727408B (en) 2017-04-18 2017-04-18 Pyridofuroxan energetic compound and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710251607.0A CN108727408B (en) 2017-04-18 2017-04-18 Pyridofuroxan energetic compound and preparation method thereof

Publications (2)

Publication Number Publication Date
CN108727408A CN108727408A (en) 2018-11-02
CN108727408B true CN108727408B (en) 2021-04-16

Family

ID=63924204

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710251607.0A Expired - Fee Related CN108727408B (en) 2017-04-18 2017-04-18 Pyridofuroxan energetic compound and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108727408B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113321666B (en) * 2020-02-28 2022-05-20 南京理工大学 Energy-containing compound based on ring-fused framework and synthetic method thereof
CN112521402A (en) * 2020-12-15 2021-03-19 北京理工大学 1,2, 4-oxadiazole [5,5] bicyclic fused ring compound and preparation method thereof
CN115746021B (en) * 2022-11-23 2024-02-13 中国工程物理研究院化工材料研究所 Synthesis method of 7-amino-6-nitrobenzofuroxan and isomer thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450108A (en) * 2012-06-04 2013-12-18 南京理工大学 Polyaminopolynitrobenzofuroxan metal complex and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450108A (en) * 2012-06-04 2013-12-18 南京理工大学 Polyaminopolynitrobenzofuroxan metal complex and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
7-氨基-6-硝基-[1,2,5]噁二唑并[3,4-b]吡啶-1-氧化物合成及性能;马丛明,等;《含能材料》;20141231;第22卷(第14期);第573页化合物3,合成路线、实验内容 *
Preparation, characterization, and properties of 7-nitrotetrazolo[1,5-f]furazano[4,5-b]pyridine 1-oxide;My Hang V. Huynh,等;《Journal of Energetic Materials》;20060902;第23卷(第2期);第100页化合物NFP,102页NFP合成路线 *

Also Published As

Publication number Publication date
CN108727408A (en) 2018-11-02

Similar Documents

Publication Publication Date Title
CN108727408B (en) Pyridofuroxan energetic compound and preparation method thereof
CN108424339B (en) Preparation method of high-nitrogen two-dimensional conjugated structure doped modified ammonium nitrate explosive crystal
CN103694181A (en) Synthetic method of 2, 6-diamino-3, 5-binitropyrazine-1-oxide
CN109627235B (en) High-energy insensitive energetic compound and synthesis method thereof
CN102250007A (en) Preparation method of 3,4-binitropyrazole
CN112194625B (en) 1, 4-dinitroamino-3, 5-dinitropyrazole oxalyldihydrazine nitrate, preparation method and application thereof
CN114230423A (en) CL-20/BODN eutectic explosive with low mechanical sensitivity and high detonation performance, preparation method and application
CN113321666B (en) Energy-containing compound based on ring-fused framework and synthetic method thereof
CN114957125B (en) Synthesis method of 4-nitro-5-nitroaminopyrazole
CN104693130A (en) Synthesis method of 2,6-diamido-3,5-dinitropyrazine-1-oxide
Xue et al. Methyl nitrate energetic compounds based on bicyclic scaffolds of furazan–isofurazan (isoxazole): syntheses, crystal structures and detonation performances
CN104496916A (en) Preparation method of 1-oxy-2, 6-diamido-3, 5-dinitropyrazine
CN114315739A (en) High-energy low-sensitivity energetic compound and preparation method thereof
CN115521265A (en) High nitrogen compound and synthesis method thereof
CN105566244A (en) Synthetic method for 3-(4-aminofurazan-3-radical)-4-(4-nitrofurazan-3-radical) furazan
CN109020906B (en) Energetic compound and synthesis method and application thereof
CN110903261B (en) Preparation method of high energy density material
CN113501771A (en) Preparation method of N- (2-aminoethyl) glycine derivative
CN114644600B (en) High-heat-stability high explosive and preparation method thereof
CN107266376B (en) LLM-105 nitramine derivatives and preparation method thereof
CN104672156B (en) 2-methyl-4-nitro-1,2,3-triazolyl-5-ammonia, and preparation method and application thereof
CN115340501B (en) Energetic ionic salt based on bitriazole compounds and synthesis method thereof
CN115925631B (en) Compound 3,3 ’ ,5,5 ’ -tetramino-4, 4 ’ -dinitro-1, 1 ’ -bipyrazoles and process for their preparation
CN110256463B (en) 7- (3, 5-diamino-2, 4, 6-trinitrophenyl) bis furazano furoxan azepanenes
CN103936592B (en) 2,4,6-trinitro--1,3-bis-(3 '-nitrostyrolene base) benzene, preparation and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210416

CF01 Termination of patent right due to non-payment of annual fee